Striatal Neuroinflammation Promotes Parkinsonism in Rats

Cited by (141)

Items 101–141 of 141

  1. Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model
    Antony Justin, Premkumar Ashwini, Jincy A. Jose, Victoria Jeyarani, S. P. Dhanabal, Chennu Manisha, Subhankar P. Mandal, Guru Bhavimani, Prabitha Prabhakaran, Shanmugam Yuvaraj et al. · 2020 · Frontiers in Neuroscience
  2. Interleukin 13 on Microglia is Neurotoxic in Lipopolysaccharide-injected Striatumin vivo
    Ah Reum Hong, Jae Geun Jang, Young Cheul Chung, So-Yoon Won, Byung Kwan Jin · 2022 · Experimental Neurobiology
  3. The Role of Exercise in Reducing Hyperlipidemia‐Induced Neuronal Damage in Apolipoprotein E‐Deficient Mice
    Yumeng Bai, Yali Feng, Bo Jiang, Yan Yang, Zuowei Pei, Qin Yang, Yanzeng Cui · 2021 · BioMed Research International
  4. PET Imaging of Fructose Metabolism in a Rodent Model of Neuroinflammation with 6-[18F]fluoro-6-deoxy-D-fructose
    Amanda J. Boyle, Emily Murrell, Junchao Tong, Christin Schifani, Andrea Narvaez, Melinda Wuest, Frederick G. West, Frank R. Wuest, Neil Vasdev · 2022 · Molecules
  5. Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages
    Kyung‐Ran Park, Chul Ju Hwang, Hyung‐Mun Yun, In Jun Yeo, Dong‐Young Choi, Pil‐Hoon Park, Hyungsook Kim, Jung Tae Lee, Young Suk Jung, Sang‐Bae Han et al. · 2020 · Stem Cell Research & Therapy
  6. Intranigral Injection of Endotoxin Suppresses Proliferation of Hippocampal Progenitor Cells
    Batoul Darwish, Farah Chamaa, Elie D. Al–Chaer, Nayef E. Saadé, Wassim G. Abou-Kheir · 2019 · Frontiers in Neuroscience
  7. Modeling neurodegeneration and neuroinflammation in Parkinson’s Disease: Animal-based strategies
    Jose Angel Morales-Garcia · 2025 · Methods in cell biology
  8. IL‐1β/IL‐1R1 signaling is involved in the propagation of α‐synuclein pathology of the gastrointestinal tract to the brain
    Bilal Muhammad, Haiying Li, Yunlu Gu, Senlin Xue, Yao Gao, Zhou Xu, Xiaoli Fang, Haohan Ding, Fang Wu, Deqin Geng et al. · 2023 · Journal of Neurochemistry
  9. Impact on Human Health of Salmonella spp. and Their Lipopolysaccharides: Possible Therapeutic Role and Asymptomatic Presence Consequences
    Mateusz Mikołajczyk, Dagmara Złotkowska, Anita Mikołajczyk · 2024 · International Journal of Molecular Sciences
  10. Exendin-4 protects the dopaminergic neurons by attenuating inflammatory responses of microglial cells via activation of AMPK
    Nikesh Rimal, Shristi Khanal, Ganesh Bohara, Dong‐Young Choi · 2025 · Neuropharmacology
  11. The Effects of Novel Formulations of Edaravone and Curcumin in the Mouse Intrastriatal Lipopolysaccharide Model of Parkinson’s Disease
    Isaac Bul Deng, Sanjay Garg, Xin‐Fu Zhou, Larisa Bobrovskaya · 2022 · Frontiers in Bioscience-Scholar
  12. Mitochondrial Complex I Is an Essential Player in LPS-Induced Preconditioning in Differentiated PC12 Cells.
    Nasim Manouchehri, Fariba Khodagholi, Leila Dargahi, Abolhassan Ahmadiani · 2019 · PubMed Central
  13. NITRIC OXIDE MEDIATED NEURODEGENERATION IN PARKINSON’S DISEASE
    Vaibhav Walia, Santlal Kansotia · 2016 · Asian Journal of Pharmaceutical and Clinical Research
  14. EFFECTS OF INTRANASALLY ADMINISTERED DNSP-11 ON THE CENTRAL DOPAMINE SYSTEM OF NORMAL AND PARKINSONIAN FISCHER 344 RATS
    James H. Sonne · 2013 · UKnowledge (University of Kentucky)
  15. Intravenous 64zn-Aspartate Mitigates Neuroinflammation and Motor Dysfunction in an Lps-Induced Parkinson’s Disease Rat Model
    Max Temnik, Mariia P. Rudyk, Alexandr Balakin, Sergey Gurin, Taisa Dovbynchuk, Roman Byshovets, Natalia Dziubenko, Ganna M. Tolstanova, Larysa M. Skivka · 2025 · Journal of Neuroimmune Pharmacology
  16. Interaction Between Nonviral Reprogrammed Fibroblast Stem Cells and Trophic Factors for Brain Repair
    Gang Liu, Hymie Anisman, Jessica Bobyn, Shawn P. Hayley · 2014 · Molecular Neurobiology
  17. Animal Models of Parkinson’s Disease
    Nidhika Sharma, Sumit Jamwal, Shamsher Singh, Harsimran Kaur Gill, Puneet Bansal · 2017 · Springer eBooks
  18. Neuroinflammation in Neurological Dysfunction and Degeneration
    Shih‐Heng Chen, Esteban A. Oyarzabal, Janine Hertzog Santos, Qingshan Wang, Lulu Jiang, Jau‐Shyong Hong · 2015 · Elsevier eBooks
  19. Anti-neuroinflammatory mechanism of safinamide in inhibiting lipopolysaccharide-induced microglial activation
    Jashann Ashwyn, Yong Qi Leong, Brianna Brianna, Khuen Yen Ng, Soi Moi Chye, Anna Pick Kiong Ling, Kenny Voon, Yin Yin Ooi, Yee Lian Tiong, Rhun Yian Koh · 2023 · Pharmaceutical Sciences Asia
  20. Understanding the Pre-Clinical Stages of Parkinson’s Disease: Where Are We in Clinical and Research Settings?
    Camilla Dalla Verde, Sri Delasmi Jayanti, Korri Elvanita El-Khobar, John A. Stanford, Claudio Tiribelli, Silvia Gazzin · 2025 · International Journal of Molecular Sciences
  21. Cross-species characterisation of microglial morphology and proliferation during ageing
    Laura M. Carr, Angus McNamara, Shannon M. Stuckey, Isabella M. Bilecki, Sanam Mustafa, Renée J. Turner, Lyndsey E. Collins‐Praino · 2026 · GeroScience
  22. Early expression of monomeric and oligomeric alpha-synuclein and reduction of tyrosine hydroxylase following intranigral injection of lipopolysaccharide
    Alma Karen Lomeli-Lepe, Silvia Josefina López‐Pérez, José Luis Castañeda‐Cabral, Mónica E. Ureña‐Guerrero · 2024 · Molecular Biology Reports
  23. Microglia activation-induced mesencephalic dopaminergic neurodegeneration — an in vitro model for Parkinson’s disease
    Bin Xing, Guoying Bing · 2012 · Frontiers in Biology
  24. Some changes in the cerebellar weights and Purkinje cells in adult Wistar rats following experimental artesunate administration
    A Ajibade · 2012 · Journal of Neuroscience and Behavioral Health
  25. A molecular dissection of neuroinflammation in ovine Batten disease
    Zhe Chen · 2016 · Lincoln University Research Archive (Lincoln University)
  26. Therapeutic potential of inhibition of the neuroinflammation induced cathepsin X: in vivo evidence
    Anja Hafner Pišlar, Larisa Tratnjek, Gordana Glavan, Nace Zidar, Marko Živin, Janko Kos · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  27. Neuroinflammation and Parkinson’s Disease: Understanding the Inflammatory Process Induced by Chronic Peripheral Injection of LPS in LRRK2 G2019S KI Mice in Correlation with Age
    Anuroopa Dinesh · 2019 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  28. Ameliorative Effects of Arctigenin From Arctium Lappa L Against LPS-induced Neuroinflammation and Cognitive Impairments in Mice
    Quan Yuan, Yiran Wu, Gang Wang, Xiang Zhou, Xiaohui Dong, Zihan Lou, Sanqiang Li, Dongmei Wang · 2022 · Research Square
  29. Early Expression of Monomeric and Oligomeric Alpha-Synuclein and Thyroxine Hydroxylase Following Intranigral Injection of Lipopolysaccharide
    Alma Karen Lomeli-Lepe, Silvia Josefina López‐Pérez, José Luis Castañeda‐Cabral, Mónica E. Ureña‐Guerrero · 2023 · SSRN Electronic Journal
  30. Germacrone attenuates memory impairment, hippocampal inflammation, and neurological deficits induced by Lipopolysaccharide in mice
    Lanyue Zhang, Zekai Tan, Ying Wang, Caixia Wu, Anjing Xu, Xiuying Lian, Yixi Zeng, Yanghe Yuan, Weini Li, Jiangling Peng · 2024 · Research Square
  31. Early expression of monomeric and oligomeric alpha-synuclein and tyrosine hydroxylase following intranigral injection of lipopolysaccharide
    Alma Karen Lomeli-Lepe, Silvia Josefina López‐Pérez, José Luis Castañeda‐Cabral, Mónica E. Ureña‐Guerrero · 2024 · Research Square
  32. Effect of L-dopa or bromocryptine alone or in combination with cannabis on oxidative stress, inflammation and neurodegeneration in experimental Parkinson’s disease
    Omar M. E. Abdel‐Salam, Eman R. Youness, Enayat Abdel Aziz Omara, Amany Ameen Sleem · 2024 · Drug Discovery
  33. Rodent models for exploring the mechanisms contributing to Parkinson's disease pathophysiology
    Joseph Allison, Susan Duty · 2025 · Handbook of behavioral neuroscience
  34. Advanced age and lipopolysaccharide influence behavioral and neurodegenerative features in LRRK2 G2019S knock-in mice
    Anuroopa Dinesh, Teresa Fortin, Hongyu Sun, Shawn P. Hayley · 2025 · Behavioural Brain Research
  35. Additional file 1 of Inhibition of vascular adhesion protein 1 protects dopamine neurons from the effects of acute inflammation and restores habit learning in the striatum
    Serena Becchi, Alberto Buson, Bernard W. Balleine · 2021 · Figshare
  36. Evaluation of the Dopaminergic System Using In Vivo PET Imaging and Post-Mortem Analyses in the Context of Mild Neurodegenerative and Neuroinflammatory PD Models
    Pauline Roost · 2020 · theses.fr (ABES)
  37. Vitamin D3 Neuroprotection Against Rotenone and MPTP in SH‐SY5Y Cells
    Ekramy Mahmoud Elmorsy, Ayat Badr Al-Ghafari, Huda Abdulaziz Al Doghaither, Nagwa M. Aly, Mai Ahmed Salem, Eman Ali Toraih, Manal Said Fawzy, Shaimaa A. Shehata · 2026 · Basic & Clinical Pharmacology & Toxicology
  38. Rodent models and accompanying in vitro strategies for studying the etiology and therapy of Parkinson's disease
    Kristina Lau, Tiago F. Outeiro, Franziska Richter · 2026 · Journal of Parkinson s Disease
  39. C-terminal Domain of the Heavy Chain of Tetanus Toxin Ameliorate Lipopolysaccharide Induced Hemiparkinsonism in Rats
    Irving Parra, José Aguilera, Yousef Tizabi, Liliana Mendieta · 2026 · Neurotoxicity Research
  40. Intra-locus coeruleus LPS administration induces anxiety-like behavior, thermal hyperalgesia, and striatal lysosomal alterations: Relevance to Parkinson’s disease
    Sara El Idrissi, Raquel Durán, Alicia Bautista‐García, Maria Isabel Sierro Caletrío, Khalid Taghzouti, Oualid Abboussi, Meryem Alamy · 2026 · Neuroscience Letters
  41. Zebrafish models provide insight into the biological classification of Parkinson's disease
    Wael Mohamed, Tiago F. Outeiro · 2026 · Elsevier eBooks